Insights
Showing 49 - 60 of 148 results
The value of investing in relationships and combining strengths cannot be overstated when it comes to balance and collaboration in the healthcare supply chain, says Vizient’s Sam Weech... read more
Artificial intelligence can provide the tool necessary to untangle complex healthcare agreements and contracts. In academic healthcare, this can support efforts to restore a funds flow model to what ... read more
A year ago, Hurricane Ian battered the Florida coast but bolstered Vizient’s approach to supply assurance. In the 12 months since, the evolved strategy has withstood some tough tests to help provider... read more
The 2024 Vizient Supplier Forum acknowledged the challenges ahead while also focusing on the silver lining that is peeking through healthcare’s “new normal”: Tough times have inspired a collaborative... read more
Recently published by Vizient Price and Supply Assurance, the Budget Impact Projections Report forecasts a 2.9% estimated supply chain rate increase for 2024, and sheds light on a few of those market... read more
By establishing genuine relationships and an environment in which everyone can shine, Margaret Steele has helped the med/surg, lab, blood management and distribution team thrive — landing her on the ... read more
Welcome to the 2024 Vizient Connections Summit... read more
Stacy Lauderdale, Vizient AVP, and John Shoen, senior clinical manager, discuss two potential approaches to preventing RSV in pediatrics expected to receive FDA decisions this year... read more
In its first 12 months, Vizient's domestic sourcing strategy has focused on building a stronger U.S.-based supply chain to increase everything from supply assurance to job creation and expedite lead ... read more
As more than 4,000 provider, supplier and Vizient attendees came together to talk healthcare’s toughest challenges, one thing became unquestionably clear — it’s time to harness the power of partnersh... read more
The controversy surrounding the FDA's recent approvals of medications for Alzheimer’s disease has raised important questions about the medications’ safety and cost, as well as their ability to delive... read more